
Half Dose DOAC for Long Term VTE Prevention, Biomarker Guided Antibiotics for Sepsis, GPT-4 Assistance for Physicians, Optimal Vasopressin Initiation for Shock, DOAC vs No AC for A fib After Intracerebral Hemorrhage, HFNC vs NIV for Respiratory Failure
About this episode
For this episode we are joined by EBM guru, Dr. Brian Locke, who deftly breaks down all of our statistics questions.
Is half dose DOAC as good as full dose DOAC for preventing VTE, and does it reduce bleeding risk? Can procalcitonin reduce duration of antibiotics for infections without compromising mortality rates? Can LLMs like GPT-4 help physicians manage patients better? Can reinforcement learning models predict when to start vasopressin in patients with septic shock? What is the risk of resuming anticoagulation in patients with atrial fibrillation and prior intracerebral hemorrhage? Is high flow nasal cannula as good as non-invasive ventilation for different types of respiratory failure? We answer all these questions and more!
Half Dose DOAC for Long Term VTE Prevention (RENOVE)
Biomarker-Guided Antibiotic Duration (ADAPT-Sepsis)
GPT-4 Assistance for Physician Performance
Optimal Vasopressin Initiation for Septic Shock (OVISS)
DOACs for A fib after ICH (PRESTIGE-AF)
High Flow Nasal Cannula vs NIV for Respiratory Failure (RENOVATE)
Music from Uppbeat (free for Creators!):
https://uppbeat.io/t/soundroll/dope
License code: NP8HLP5WKGKXFW2R
Get every episode summarized
Each time Last Week in Medicine publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Last Week in Medicine

Catheter Directed Fibrinolysis for Acute PE (HI-PEITHO), NEWS2 Plus Procalcitoni...
Last Week in Medicine

Bleeding Risk with Apixaban vs Rivaroxaban for Acute VTE (COBRRA), Left Atrial A...
Last Week in Medicine

2026 ACC/AHA Guidelines for Acute Pulmonary Embolism
Last Week in Medicine

Hematopoietic Stem Cell Gene Therapy for Cystinosis
Last Week in Medicine